You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Global Nasal Drug Delivery Devices Market The Global Nasal Drug Delivery Devices Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $9.94 billion in 2013 and expected to be $15.02 billion by 2018, growing at a CAGR of 8.6%. The Nasal Drug Delivery Devices Market analyzes the market by segments such as Nasal Drops, Nasal Spray, Nasal Inhalers, Other Nasal Drug Delivery Technologies.The prominent players in the Market are 3M, Pfizer, Merck, GlaxoSmithKline (GSK), OptiNose AS, MedImmune, Kurve Technology, Inc. |
Upcoming |
|
|
Ocular Drug Delivery Ocular Drug Delivery and Oral Drug Delivery, |
Upcoming |
|
|
Optical Imaging The market was estimated at $915.75 million in 2013 and expected to be $1.9 billion by 2018, growing at a CAGR of 11.4%. The report “Optical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices by 2 segments such as Diffusive Optical Imaging also known as; Near-Infrared Optical tomography (NIROT), Diffuse Optical Tomography (DOT) or Optical Diffusion Tomography (ODT) and Ballistic Optical Imaging. Geographically, the market is divided into four main regions such as; North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Biosimilars Biosimilars and Chromatography, E-Clinical Trial... |
Upcoming |
|
|
Donor Apheresis Donor Apheresis and Therapeutic Apheresis adds up to total |
Upcoming |
|
|
Therapeutic Apheresis Therapeutic Apheresis and Donor Apheresis adds up to total Apheresis... |
Upcoming |
|
|
Apheresis Devices The market for global apheresis devices was pegged at $1.347 billion in 2013 and expected to reach $2.886 billion by 2018, growing at a CAGR of 11.5% during the forecast period. The report on the market for global apheresis devices analyzes the market by three main segments: applications, procedures, and technologies. Geographically, the market is mainly segmented into North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW). The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
Apheresis Disposables The report “Global Apheresis disposables Market forecast, 2008-2018 “analyzes the market of disposables by 3 main segments such as by applications, procedures, and technologies. Geographically, the market is mainly segmented into North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Global Therapeutic Automation Market The Global Therapeutic Automation Market was pegged at $13,283 million in 2013 and expected to be $22,304 million by 2018, growing at a CAGR of 10.9%. The report “Therapeutic Automation Market forecast, 2012-2018 “analyzes the market by 2 segments such as Surgical and non-surgical automation market. Surgical Automation market is again subdivided into 5 types namely; surgical robotics, intelligent operating room, Intraoperative Imaging, Surgical Navigation and Surgical Stimulators and Non-surgical Automation market is again subdivided into defibrillator and automated medication system. The main companies operating in therapeutic automation market and extensively covered in this report are Accuray, Intuitive Surgical, Zoll Medical Corporation, Boston Scientific, Asahi Kasei and others. |
Upcoming |
|
|
Lab and Pharmacy Automation The Global Lab & Pharmacy Automation Market, mainly driven by product innovations, time efficiency and operational efficiency, was pegged at $5517.6 million in 2013 and expected to be $8724.9 million by 2018, growing at a CAGR of 9.6%. |
Upcoming |
|
|
Hemodynamic monitoring devices The “Global Hemodynamic Monitors Market”, mainly driven by increase in the number of Hypertension cases and Diabetic population. The report “Global Hemodynamic Monitors Market forecast, 2012-2020” analyzes the market of devices by 4 segments such as BP Monitors, Blood Glucose monitors, Blood gas & Electrolyte Analyzers and Cholesterol monitors. The main companies operating in Hemodynamic Monitors market and extensively covered in this report are Omron Healthcare, Microlife, A&D Medical, GE Healthcare, Roche, Edward Life Sciences, Johnson & Johnson, Elekta, etc. |
Upcoming |
|
|
Neuromonitoring devices The “Global Neuromonitoring devices Market”, mainly driven by increase in the number of cardiovascular diseases, was pegged at $ 832 million in 2012 and expected to be $ 1595 million by 2020, growing at a CAGR of 8.5%. The market has 5 segments such as Electroencephalographs (EEG), Transcranial Doppler (TCD), Magnetoencephalographs (MEG), Cerebral oximetry monitors, Intracranial pressure (ICP) monitors. The key players in the market are Natus Medical (U.S.), Nihon Kohden (Japan), Compumedics (Australia), Integra Life Sciences (U.S.), and Elekta (Sweden). |
Upcoming |
|
|
Cardiac monitoring devices Cardiac monitoring devices and Hemodynamic monitoring devices, |
Upcoming |
|
|
Fetal and neonatal monitors The “Global Fetal and neonatal monitors Market”, mainly driven by increase in the number of birth rates and natality, was pegged at $ 918 million in 2012 and expected to be $ 1350 million by 2020, growing at a CAGR of 4.9%. The market has 2 segments such as Ultrasound Fetal Dopplers and Internal Fetal monitors. The major players are Philips Healthcare (Netherlands), GE Healthcare (U.K.), Drager Medical (Germany), Spacelabs (U.S.), and Welch Allyn (U.S.). |
Upcoming |
|
|
Respiratory monitors The “Global Respiratory monitors Market”, mainly driven by increase in the number of respiratory diseases, was pegged at $ 1.58 billion in 2012 and expected to be $ 2.77 billion by 2020, growing at a CAGR of 7.2%. It analyzes the market of monitors by 5 segments such as Capnograph, Spirometers, Anesthesia monitors, Sleep Apnea monitors and Pulse oximeters. The key players are GE Healthcare (U.K.), Philips Healthcare (Netherlands), Drager Medical (Germany), and Covidien (U.S.). |
Upcoming |
|
|
Multi-parameter monitoring devices The “Global Multiparameter monitoring devices Market”, is one of the major markets in patient monitoring accounting for 19.6% of the total market share mainly driven by increasing number of hospitals, was pegged at $ 3.31 billion in 2012 and expected to be $ 4.8 billion by 2020, growing at a CAGR of 4.7%. It has 3 segments such as high, mid and low strips. The key players are GE Healthcare (U.K.), Philips Healthcare (Netherlands), Drager Medical (Germany), and Mindray Medical Systems (China) |
Upcoming |
|
|
Remote patient monitoring devices The “Global Remote patient monitoring devices Market”, mainly driven by Government regulations to curb healthcare costs, was pegged at $ 512 million in 2012 and expected to be $ 895 million by 2020, growing at a CAGR of 7.8%. The market has 2 segments such as External Remote Patient Monitoring Devices and Implantable Remote Patient Monitoring Devices. The main companies operating in Remote patient monitor market and extensively covered in this report are Honeywell (U.S.), Carematix (U.S.), Philips (The Netherlands), Bosch (U.S.), Telcomed (Ireland), Intel (U.S.), Aerotel (Israel), and Tunstall (U.K.). |
Upcoming |
|
|
Temperature monitors The “Global Temperature monitors Market”, mainly driven by Government regulations to curb healthcare costs, was pegged at $ 630 million in 2012 and expected to be $ 1010 billion by 2020, growing at a CAGR of 7.2%. The market has 4 segments by product such as mercury-filled, electronic, digital and infrared and temperature strips. The key players of Temperature monitors market are AMETEK, Inc, Analog Device, Autoliv Inc and Freescale Semiconductor. |
Upcoming |
|
|
Cardiac Rhythm Management Devices The Global Cardiac Rhythm Management Devices Market, was pegged at $ 10.9 billion in 2012 and expected to be $ 20.6 billion by 2018, growing at a CAGR of 10.6%. The Cardiac Rhythm Management Devices Market is segmented by Type of devices, Geography, Companies and Macroindicator. Deep dive analysis of the major players of this market are considered in this report. |
Upcoming |
|
|
Weight Monitors The “Global Weight monitors Market”, mainly driven by Government regulations to curb healthcare costs, was pegged at $ 2.2 billion in 2012 and expected to be $ 2.92 billion by 2020, growing at a CAGR of 3.5%. The market of monitors has 2 segments such as analog scales and digital weighing scales. The major key players covered in the report are Seca (U.S.), Tanita (India), LifeWatch AG (Switzerland), and A&D Company Ltd. (Japan). |
Upcoming |
Healthcare
